Dr. Amandeep Salhotra
Claim this profileCity of Hope Medical Center
Studies Acute Myeloid Leukemia
Studies T-Lymphoblastic Leukemia/Lymphoma
12 reported clinical trials
21 drugs studied
Area of expertise
1Acute Myeloid Leukemia
IDH positive
HLA-A positive
HLA-A negative
2T-Lymphoblastic Leukemia/Lymphoma
IDH positive
TP53 negative
PML-RARA negative
Affiliated Hospitals
Clinical Trials Amandeep Salhotra is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
Orca-T and Radiation Therapy
for Leukemia
This phase I trial tests the side effects and best dose of total marrow lymphoid irradiation along with chemotherapy, with fludarabine and melphalan, with or without thiotepa, in combination with Orca-T cells for patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) or myelodysplastic syndrome (MDS). Total marrow and lymphoid irradiation is a targeted form of total body irradiation that uses intensity-modulated radiation therapy to target marrow, lymph node chains, and the spleen. It is designed to reduce radiation-associated side effects and maximize the radiation therapeutic effect. Giving chemotherapy with medications such as thiotepa, fludarabine, and melphalan before a treatment with stem cells helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. Orca-T cells take cells from a donor and remove some of the T cells and replace them with partially engineered T cells in order to induce better tolerance in patients. Giving total marrow and lymphoid irradiation and chemotherapy followed by Orca -T cells may be an effective treatment for patients with AML, ALL or MDS.
Recruiting1 award Phase 1
More about Amandeep Salhotra
Clinical Trial Related7 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Amandeep Salhotra has experience with
- CD6-CAR Tregs
- Fludarabine
- Melphalan
- Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
- Thiotepa
- Total Marrow And Lymphoid Irradiation
Breakdown of trials Amandeep Salhotra has run
Acute Myeloid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amandeep Salhotra specialize in?
Amandeep Salhotra focuses on Acute Myeloid Leukemia and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Acute Myeloid Leukemia has involved IDH positive patients, or patients who are HLA-A positive.
Is Amandeep Salhotra currently recruiting for clinical trials?
Yes, Amandeep Salhotra is currently recruiting for 7 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Amandeep Salhotra has studied deeply?
Yes, Amandeep Salhotra has studied treatments such as CD6-CAR Tregs, Fludarabine, Melphalan.
What is the best way to schedule an appointment with Amandeep Salhotra?
Apply for one of the trials that Amandeep Salhotra is conducting.
What is the office address of Amandeep Salhotra?
The office of Amandeep Salhotra is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.